ReviewCJC open2026
Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy.
Review in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited genetic cardiac disorder that increasingly is being diagnosed in people of childbearing age, due to advancements in genetic testing and the evolution of screening guidelines. Many women may first present with HCM during pregnancy, which can lead to adverse maternal and fetal outcomes if not appropriately managed. Although most women with HCM tolerate pregnancy well, it can be associated with increased cardiovascular risks, including heart failure, arrhythmias, and adverse fetal outcomes, particularly among those with suboptimal baseline functional status. Medical therapy remains the mainstay of management of HCM in pregnancy, as only a limited number of studies have been done on the safety and effectiveness of invasive procedures, such as alcohol septal ablation and cardiac myomectomy, in pregnant women. Large cohort studies of women with HCM are very limited, and management practices vary within centres, with no protocolized care. This review aims to summarize the unique challenges faced by pregnant women with HCM, highlighting the need for large multicentric studies and more standardized care protocols to optimize maternal and fetal outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.